erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
cuomo's plan requires the health department to post tick collection and testing results to health data ny and make the data available to the public, which was not released before..